Ihara K - Search Results

1

Real-world evidence of fremanezumab for treating migraine in Japan: a retrospective study.

Ohtani S, Watanabe N, Ihara K, Takahashi N, Miyazaki N, Ishizuchi K, Takemura R, Hori S, Nakahara J, Takizawa T. Ohtani S, et al. Among authors: ihara k. BMC Neurol. 2023 Nov 14;23(1):404. doi: 10.1186/s12883-023-03449-3. BMC Neurol. 2023. PMID: 37964188 Free PMC article.

2

Predicting response to CGRP-monoclonal antibodies in patients with migraine in Japan: a single-centre retrospective observational study.

Ihara K, Ohtani S, Watanabe N, Takahashi N, Miyazaki N, Ishizuchi K, Hori S, Takemura R, Nakahara J, Takizawa T. Ihara K, et al. J Headache Pain. 2023 Mar 9;24(1):23. doi: 10.1186/s10194-023-01556-7. J Headache Pain. 2023. PMID: 36890436 Free PMC article.

3

Switching between anti-calcitonin gene-related peptide monoclonal antibodies: A comparison of monthly and quarterly dosing.

Ihara K, Ohtani S, Watanabe N, Takahashi N, Miyazaki N, Takemura R, Hori S, Nakahara J, Takizawa T. Ihara K, et al. J Neurol Sci. 2023 Oct 15;453:120811. doi: 10.1016/j.jns.2023.120811. Epub 2023 Sep 16. J Neurol Sci. 2023. PMID: 37757639 Free article.

4

Metabolic and toxicological considerations regarding CGRP mAbs and CGRP antagonists to treat migraine in COVID-19 patients: a narrative review.

Takizawa T, Ihara K, Uno S, Ohtani S, Watanabe N, Imai N, Nakahara J, Hori S, Garcia-Azorin D, Martelletti P. Takizawa T, et al. Among authors: ihara k. Expert Opin Drug Metab Toxicol. 2023 Dec;19(12):951-967. doi: 10.1080/17425255.2023.2280221. Epub 2024 Jan 12. Expert Opin Drug Metab Toxicol. 2023. PMID: 37925645 Review.

5

Response to letter: "Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule" by Suzuki et al.

Ihara K, Ohtani S, Watanabe N, Takahashi N, Hori S, Nakahara J, Takizawa T. Ihara K, et al. J Neurol Sci. 2023 Dec 15;455:122785. doi: 10.1016/j.jns.2023.122785. Epub 2023 Nov 13. J Neurol Sci. 2023. PMID: 37981532 No abstract available.

6

Potential benefits and possible risks of CGRP-targeted multitherapy in migraine.

Ihara K, Takizawa T, Watanabe N, Nakahara J, Martelletti P. Ihara K, et al. Expert Opin Drug Metab Toxicol. 2024 Jan-Feb;20(1-2):1-4. doi: 10.1080/17425255.2024.2316131. Epub 2024 Feb 12. Expert Opin Drug Metab Toxicol. 2024. PMID: 38323326 No abstract available.

7

The impact of primary headaches on disability outcomes: a literature review and meta-analysis to inform future iterations of the Global Burden of Disease study.

Waliszewska-Prosół M, Montisano DA, Antolak M, Bighiani F, Cammarota F, Cetta I, Corrado M, Ihara K, Kartamysheva R, Petrušić I, Pocora MM, Takizawa T, Vaghi G, Martelletti P, Corso B, Raggi A; European Headache Federation School of Advanced Studies (EHF-SAS). Waliszewska-Prosół M, et al. Among authors: ihara k. J Headache Pain. 2024 Mar 4;25(1):27. doi: 10.1186/s10194-024-01735-0. J Headache Pain. 2024. PMID: 38433202 Free PMC article. Review.

8

CGRP-monoclonal antibodies in Japan: insights from an online survey of physician members of the Japanese headache society.

Takizawa T, Ihara K, Watanabe N, Takemura R, Takahashi N, Miyazaki N, Shibata M, Suzuki K, Imai N, Suzuki N, Hirata K, Takeshima T, Nakahara J. Takizawa T, et al. Among authors: ihara k. J Headache Pain. 2024 Mar 15;25(1):39. doi: 10.1186/s10194-024-01737-y. J Headache Pain. 2024. PMID: 38491415 Free PMC article.

9

Application of Artificial Intelligence in the Headache Field.

Ihara K, Dumkrieger G, Zhang P, Takizawa T, Schwedt TJ, Chiang CC. Ihara K, et al. Curr Pain Headache Rep. 2024 Oct;28(10):1049-1057. doi: 10.1007/s11916-024-01297-5. Epub 2024 Jul 8. Curr Pain Headache Rep. 2024. PMID: 38976174 Review.

10

Real-world Efficacy of Erenumab on Migraine-associated Symptoms and Patient-reported Satisfaction Levels: A Retrospective Study in Japan.

Ihara K, Takahashi N, Ohtani S, Watanabe N, Ishizuchi K, Takemura R, Tokuyasu D, Sekiguchi K, Miyazaki N, Imai S, Hori S, Nakahara J, Takizawa T. Ihara K, et al. Intern Med. 2024 Aug 8. doi: 10.2169/internalmedicine.4037-24. Online ahead of print. Intern Med. 2024. PMID: 39111884 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

908 results

Search Page

Filters